Taysha Gene Therapies Azioni (NASDAQ: TSHA)

Taysha Gene Therapies (NASDAQ:TSHA) Azioni, Quote.MetaTitle.unusual-options

Taysha Gene Therapies

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies Inc

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

AnaptysBio

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

CareDx

CureVac

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Immatics

Inhibrx Biosciences

Kodiak Sciences

Kura Oncology

MiMedx Group

Nanobiotix

Nurix Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Relay Therapeutics

Rezolute

Sana Biotechnology

Tango Therapeutics

UroGen Pharma

Xencor

Taysha Gene Therapies (TSHA) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Comments

Taysha Gene Therapies Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO